Clinical Trials
22 trialsNCT06989437 2026-05-20
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Pfizer
Phase 2/3 Recruiting
NCT06754722 2026-04-07
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
5 Point App, Inc.
Phase NA Recruiting
NCT06137833 2025-10-01
Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy
Pharmanutra S.p.a.
Phase NA Recruiting
NCT05440227 2025-06-05
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
PhytoHealth Corporation
Phase 2 Recruiting
NCT00518869 2025-06-04
Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue
PhytoHealth Corporation
Phase 2/3 Terminated
NCT00523107 2025-06-04
PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
PhytoHealth Corporation
Phase 2/3 Completed
NCT02077621 2025-06-04
Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer
PhytoHealth Corporation
Phase 2 Withdrawn
NCT05546476 2025-05-31
PROACC-1
Pfizer
Phase 2 Completed
NCT05212701 2024-04-30
To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer
Dompé Farmaceutici S.p.A
Phase 2 Withdrawn
NCT05664009 2024-04-05
The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults
Canada Royal Enoch Phytomedicine Co., Ltd.
Phase 2 Unknown
NCT05852002 2024-01-17
A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer
Nakhia Impex LLC
Phase NA Completed
NCT04803305 2024-01-12
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Pfizer
Phase 1 Completed
NCT04299048 2023-12-14
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Pfizer
Phase 1 Completed
NCT00866970 2020-07-09
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
CSL Behring
Phase 2 Completed
NCT02434367 2017-12-14
WWE
The West Clinic, Memphis
Phase 2 Completed
NCT00825227 2017-11-17
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Terminated
NCT02645175 2016-10-21
Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
Meriyana Bio Inc.
Phase 2 Terminated
NCT01160380 2014-11-06
A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma
Oncotherapeutics
Phase 3 Completed
NCT01206335 2012-11-27
Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia
Ohr Pharmaceutical Inc.
Phase 2 Unknown
NCT00758407 2010-01-13
EMF
Medice Arzneimittel Pütter GmbH & Co KG
Phase 2/3 Completed
NCT00117039 2008-10-15
A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia
Amgen
Phase 4 Completed
NCT00047476 2005-06-24
D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients
Celgene
Phase 2 Completed